Cargando…

Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS

SIMPLE SUMMARY: RAS oncoproteins are considered undruggable cancer targets. Nearly 15% of cases of bladder cancer have a mutation of HRAS. The active HRAS contributes to the tumor progression and the risk of recurrence. Using our novel gene expression screening platform, pterostilbene was identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi-Ting, Huang, Zi-Yi, Tang, Han-Hsuan, Kuo, Wan-Ting, Wu, Shan-Ying, Lan, Sheng-Hui, Chang, Kai-Hsun, Lin, Pin-Lun, Lee, Ming-Fen, Cheng, Hung-Chi, Liu, Hsiao-Sheng, Huang, Chi-Ying F., Huang, Guan-Cheng, Su, Chun-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650649/ https://www.ncbi.nlm.nih.gov/pubmed/33036162 http://dx.doi.org/10.3390/cancers12102869

Ejemplares similares

Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer
por: Chen, Rong-Jane, et al.
Publicado: (2018)

Enhancement of Anticancer Potential of Pterostilbene Derivative by Chalcone Hybridization
por: Tang, Kai-Wei, et al.
Publicado: (2021)

Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS
por: Yee, Christopher H., et al.
Publicado: (2019)

MTH1 expression is required for effective transformation by oncogenic HRAS
por: Giribaldi, Maria G., et al.
Publicado: (2015)

Induction of Autophagy by Pterostilbene Contributes to the Prevention of Renal Fibrosis via Attenuating NLRP3 Inflammasome Activation and Epithelial-Mesenchymal Transition
por: Wang, Ying-Jan, et al.
Publicado: (2020)

MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells
por: Riemondy, Kent, et al.
Publicado: (2015)

Pterostilbene Enhances Cytotoxicity and Chemosensitivity in Human Pancreatic Cancer Cells
por: Hsu, Yi-Hao, et al.
Publicado: (2020)

Analysis of FGFR3 and HRAS genes in patients with bladder cancer
por: Homami, Ameneh, et al.
Publicado: (2020)

Autophagy-inducing effect of pterostilbene: A prospective therapeutic/preventive option for skin diseases
por: Chen, Rong-Jane, et al.
Publicado: (2016)

Modulation of Innate Immune Toxicity by Silver Nanoparticle Exposure and the Preventive Effects of Pterostilbene
por: Chen, Rong-Jane, et al.
Publicado: (2021)

Biological actions and molecular effects of resveratrol, pterostilbene, and 3′-hydroxypterostilbene
por: Tsai, Hui-Yun, et al.
Publicado: (2016)

Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence
por: Li, Jenny J., et al.
Publicado: (2021)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Pterostilbene modulates the suppression of multidrug resistance protein 1 and triggers autophagic and apoptotic mechanisms in cisplatin-resistant human oral cancer CAR cells via AKT signaling
por: Chang, Hui-Ping, et al.
Publicado: (2018)

Pterostilbene Changes Epigenetic Marks at Enhancer Regions of Oncogenes in Breast Cancer Cells
por: Harandi-Zadeh, Sadaf, et al.
Publicado: (2021)

Kita Driven Expression of Oncogenic HRAS Leads to Early Onset and Highly Penetrant Melanoma in Zebrafish
por: Santoriello, Cristina, et al.
Publicado: (2010)

Early and Late Induction of KRAS and HRAS Proto-Oncogenes by Reactive Oxygen Species in Primary Astrocytes
por: Messina, Samantha, et al.
Publicado: (2017)

p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1
por: Jung, Jewon, et al.
Publicado: (2021)

The Structure-Activity Relationship of Pterostilbene Against Candida albicans Biofilms
por: Hu, Dan-Dan, et al.
Publicado: (2017)

Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation
por: Schwartz, Michal, et al.
Publicado: (2020)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
por: Chuang, Fei-Chi, et al.
Publicado: (2018)

Evaluation of Bladder Diary Parameters Based on Correlation with the Volume at Strong Desire to Void in Filling Cystometry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2013)

FAM111B Acts as an Oncogene in Bladder Cancer
por: Huang, Ning, et al.
Publicado: (2023)

Oncogenic Roles of Polycomb Repressive Complex 2 in Bladder Cancer and Upper Tract Urothelial Carcinoma
por: Huang, Eric Yi-Hsiu, et al.
Publicado: (2022)

Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function
por: Ali, Sadaqat, et al.
Publicado: (2023)

Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis
por: Wang, Ying-Jan, et al.
Publicado: (2017)

Pterostilbene in Cancer Therapy
por: Obrador, Elena, et al.
Publicado: (2021)

Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions
por: Tzeng, Wen-Sheng, et al.
Publicado: (2021)

Potential Therapeutic Roles of Tanshinone IIA in Human Bladder Cancer Cells
por: Chiu, Sheng-Chun, et al.
Publicado: (2014)

Bladder volume reproducibility after water consumption in patients with prostate cancer undergoing radiotherapy: A systematic review and meta-analysis
por: Chen, Hsiao-Hsuan, et al.
Publicado: (2021)

Long Noncoding RNA LOC550643 Acts as an Oncogene in the Growth Regulation of Colorectal Cancer Cells
por: Wu, Hsuan Franziska, et al.
Publicado: (2022)

Case Report: Sequential postzygotic HRAS mutation and gains of the paternal chromosome 11 carrying the mutated allele in a patient with epidermal nevus and rhabdomyosarcoma: evidence of a multiple-hit mechanism involving HRAS in oncogenic transformation
por: Zuntini, Roberta, et al.
Publicado: (2023)

Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis
por: Oba, Daiju, et al.
Publicado: (2017)

Expression of oncogenic HRAS (G12V) causes defects in control of cell size in NIH 3T3 cells
por: DeWitt, Jerry T., et al.
Publicado: (2023)

Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation
por: Pan, Min-Hsiung, et al.
Publicado: (2011)

Pterostilbene attenuates intestinal epithelial barrier loss induced by high loading intensity of exercise
por: Zhang, Lidong, et al.
Publicado: (2022)

Estrogen Receptor-α36 Is Involved in Pterostilbene-Induced Apoptosis and Anti-Proliferation in In Vitro and In Vivo Breast Cancer
por: Pan, Chi, et al.
Publicado: (2014)

The Antithrombotic Agent Pterostilbene Interferes with Integrin α(IIb)β(3)-Mediated Inside-Out and Outside-In Signals in Human Platelets
por: Huang, Wei-Chieh, et al.
Publicado: (2021)

Impact of a home health care program for disabled patients in Taiwan: A nationwide population-based cohort study
por: Lee, Yi-Hsuan, et al.
Publicado: (2019)

microRNA-324 plays an oncogenic role in bladder cancer cell growth and motility
por: Tsai, Kuo-Wang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t2qf435dhfljam031svt267uft